Proton therapy enhancement with gold, platinum, and iridium nanoparticle: A cellular-scale Geant4-DNA study
Pages 1-14
https://doi.org/10.22034/rpe.2026.575951.1345
Fatemeh Habibi, Zohreh Parang, Nasrin Hoseini-Motlagh, Alireza Keshavarz
Abstract Combining nanoparticles (NPs) with proton therapy holds promise for improving treatment gain. Prior simulation studies often lack clinical beam realism and comprehensive radiobiological endpoints, leading to conflicting results. This study employs a Geant4-DNA Monte Carlo simulation to compare the physical and radiobiological enhancement of Au, Pt, and Ir NPs in a human cell under a clinically relevant Spread-Out Bragg Peak proton beam. A 62.8 MeV SOBP was simulated, then, phase-space files at the beam's entrance, plateau, and distal edge were obtained. They used to irradiate a fibroblast cell containing 30 mg/g NPs in the cytoplasm. Three NP sizes of 10, 50, and 100 nm were investigated at each phase-space. We calculated the dose enhancement factor (DEF) and total DNA damage enhancement. Furthermore, cell survival curves were predicted using the Two-Lesion Kinetic model. The results indicated that Ir NPs yielded the highest physical dose enhancement (up to 4.21% for 10 nm size), followed by Pt NPs (up to 4.10%). Smaller NPs tend to present a higher DEF than larger NPs. DNA damage yields increased with linear energy transfer (LET), with the distal SOBP distal edge showing the greatest enhancement. Cell survival curves indicated a detectable reduction in survival fraction for Ir > Pt > Au NPs at the distal edge, correlating with increased complex DNA damage. Under clinically realistic simulation conditions, high atomic number and high density NPs like Ir provide a modest but consistent physical and radiobiological enhancement in proton therapy, most pronounced at the high-LET Bragg peak.
















